Skip to main content
SpringerLink
Log in

IBD: Management of Symptomatic Anal Fistulas in Patients with Crohn’s Disease

  • Chapter
  • First Online:
Difficult Decisions in Colorectal Surgery

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY))

  • 1125 Accesses

Abstract

Approximately 30 % of patients with Crohn’s disease (CD) will have or develop perianal fistulas (PF) during the course of their disease. Not only do symptomatic PF cause pain and drainage, they may also lead to sepsis, incontinence, restriction of activities, and decreased quality of life. Ultimately, some patients may end up with permanent fecal diversion either due to progression of disease or in some cases owing to complications from aggressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125:1508–30.

    Article  PubMed  Google Scholar 

  2. vanKoperen PJ, Safiruddin F, Bemelman WA, Slores JFM. Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg. 2009;96:675–9.

    Article  CAS  Google Scholar 

  3. Sangwan YP, Schoetz DJ, Murray JJ, Roberts PL, Coller JA. Perianal Crohn’s disease results of local surgical treatment. Dis Colon Rectum. 1996;39:529–35.

    Article  CAS  PubMed  Google Scholar 

  4. Thorton M, Solomon MJ. Long-term indwelling seton for complex anal fistulas in Crohn’s disease. Dis Colon Rectum. 2005;48:459–63.

    Article  Google Scholar 

  5. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with Infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.

    Article  PubMed  Google Scholar 

  6. Pearson DC, Gary RM, Gordon HF, Sutherland LR. Azathioprine and 6-Mecaptopurine in Crohn’s disease. Ann Intern Med. 1995;122:132–42.

    Article  Google Scholar 

  7. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999;340:1398–405.

    Article  CAS  PubMed  Google Scholar 

  8. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–85.

    Article  CAS  PubMed  Google Scholar 

  9. Hanauer SB, Sandborn WJ, Rutgeets P. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-1 trial. Gastroenterology. 2006;130:323–32.

    Article  CAS  PubMed  Google Scholar 

  10. Sandborn WJ, Rutgeets P, Enns R, et al. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med. 2007;146:829–38.

    Article  PubMed  Google Scholar 

  11. Colombel JF, Sandborn WJ, Rutgeerts P. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology. 2007;132:52–65.

    Article  CAS  PubMed  Google Scholar 

  12. West R, Van Der Woude CJ, Hansen BE, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn’s disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2004;20:1329–36.

    Article  CAS  PubMed  Google Scholar 

  13. Dewint P, Hansen BE, Verhey E, et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomized, double-blind, placebo controlled trial (ADAFI). Gut. 2014;63:292–9.

    Article  CAS  PubMed  Google Scholar 

  14. vanBodegraven AA, Sloots CE, Felt-Bersma RJ, Meuwissen SG. Endosonographic evidence of persistence of Crohn’s disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2002;45:39–45.

    Article  Google Scholar 

  15. Grimaud JC, Munoz-Bongrand N, Siproudhis L, et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2010;138:2275–81.

    Article  CAS  PubMed  Google Scholar 

  16. O’Riordan JM, Datta I, Johnston C, Baxter NN. A systematic review of the anal fistula plug for patients with Crohn’s and non-Crohn’s related Fistula-in-ano. Dis Colon Rectum. 2012;55:351–8.

    Article  PubMed  Google Scholar 

  17. Soltani A, Kaiser A. Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano. Dis Colon Rectum. 2010;53:486–95.

    Article  PubMed  Google Scholar 

  18. Makowiec F, Jehle EC, Becker HD, Starlinger M. Clinical course after transanal advancement flap repair of perianal fistula inpatients with Crohn’s disease. Br J Surg. 1995;82:603–6.

    Article  CAS  PubMed  Google Scholar 

  19. Hyman N. Endoanal advancement flap repair for complex anorectal fistulas. Am J Surg. 1999;178:337–40.

    Article  CAS  PubMed  Google Scholar 

  20. Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn’s Disease. Ann Surg. 2014;260:1057–61.

    Article  PubMed  Google Scholar 

  21. Singh S, Ding NS, Mathis KL, et al. Systematic review with meta-analysis: fecal diversion for management of perianal Crohn’s disease. Aliment Pharmacol Ther. 2015;42:783–92.

    Article  CAS  PubMed  Google Scholar 

  22. Mueller MH, Geis M, Glatzle J, et al. Risk of fecal diversion in complicated perianal Crohn’s disease. J Gastrointest Surg. 2007;11:529–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Molendijk I, Nuij VJAA, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn’s disease fistula. Inflamm Bowel Dis. 2014;20:2022–8.

    Article  PubMed  Google Scholar 

  24. Gaertner WB, Decanini A, Mellgren A, et al. Does Infliximab infusion impact results of operative treatment for Crohn’s perianal fistulas. Dis Colon Rectum. 2007;50:1754–60.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA, USA

    Lisa S. Poritz

Authors
  1. Lisa S. Poritz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa S. Poritz .

Editor information

Editors and Affiliations

  1. Medical Center, University of Chicago, Chicago, Illinois, USA

    Neil Hyman

  2. Medical Center, University of Chicago, Chicago, Illinois, USA

    Konstantin Umanskiy

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Poritz, L.S. (2017). IBD: Management of Symptomatic Anal Fistulas in Patients with Crohn’s Disease. In: Hyman, N., Umanskiy, K. (eds) Difficult Decisions in Colorectal Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-40223-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40223-9_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40222-2

  • Online ISBN: 978-3-319-40223-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation